1 Min Read
* TESARO ANNOUNCES AVAILABILITY OF VARUBI® (ROLAPITANT) IV FOR DELAYED NAUSEA AND VOMITING ASSOCIATED WITH CANCER CHEMOTHERAPY IN THE UNITED STATES Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.